NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Sees Significant Growth in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,921 shares, an increase of 249.7% from the March 15th total of 1,693 shares. Based on an average trading volume of 12,095 shares, the days-to-cover ratio is presently 0.5 days.

NRx Pharmaceuticals Price Performance

Shares of NASDAQ NRXPW traded down $0.01 during trading on Friday, hitting $0.01. 155,698 shares of the company were exchanged, compared to its average volume of 23,408. NRx Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.18. The firm’s fifty day moving average price is $0.03 and its 200 day moving average price is $0.07.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for neuropsychiatric and neurodegenerative disorders. The company’s research pipeline includes small‐molecule candidates designed to address underlying pathophysiological mechanisms implicated in conditions such as Rett syndrome, Alzheimer’s disease and Long COVID. Leveraging a proprietary formulation and delivery approach, NRx seeks to advance compounds that have demonstrated safety in prior studies toward new indications with significant unmet medical need.

Among its lead programs, NRx is developing NP-120 (sarizotan) for the treatment of Rett syndrome, a rare genetic disorder that impacts brain development in young girls.